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induced increase in cortical activity triggers lactate release into the extracellular space, and this correlates
with a fast and prominent lactate dip in astrocytes. The immediate drop in astrocytic lactate concentra-
tion and the parallel increase in extracellular lactate levels underline an activity-dependent lactate release
from astrocytes. Moreover, when ฀-adrenergic signalling is blocked or the brain is depleted of glycogen,
the arousal-evoked cellular lactate surges are significantly reduced. We provide in vivo evidence that
cortical activation upon arousal triggers lactate release from astrocytes, a rise in intracellular lactate
levels mediated by ฀-adrenergic signalling and the mobilization of lactate from glycogen stores.
DOI: https://doi.org/10.1038/s42255-020-0170-4





Zuend, Marc; Saab, Aiman S; Wyss, Matthias T; Ferrari, Kim David; Hösli, Ladina; Looser, Zoe J;
Stobart, Jillian L; Duran, Jordi; Guinovart, Joan J; Barros, L Felipe; Weber, Bruno (2020). Arousal-
induced cortical activity triggers lactate release from astrocytes. Nature Metabolism, 2(2):179-191.
DOI: https://doi.org/10.1038/s42255-020-0170-4
1 
Arousal-induced cortical activity triggers lactate release from astrocytes 1 
 2 
Marc Zuend1,2, Aiman S Saab1,2,4, Matthias T Wyss1,2,4, Kim David Ferrari1,2, Jillian Stobart1,2, L Felipe 3 
Barros3 and Bruno Weber1,2 * 4 
 5 
(1) Institute of Pharmacology and Toxicology, University of Zurich, 8057 Zurich, Switzerland 6 
(2) Neuroscience Center Zurich, University of Zurich and ETH Zurich, 8057 Zurich, Switzerland 7 
(3) Centro de Estudios Científicos, Valdivia 5110466, Chile 8 
(4) These authors contributed equally to this work. 9 
 10 
* Correspondence: bweber@pharma.uzh.ch  11 
2 
Abstract 12 
Arousal-induced release of noradrenaline and β-adrenergic signaling impacts long-term memory 13 
formation by stimulating astrocytic lactate production. However, the temporal relationship between 14 
cortical activity, β-adrenergic signaling and lactate dynamics in vivo are poorly understood. Here, we 15 
investigated arousal-evoked lactate dynamics in cortical neurons and astrocytes in awake mice. A brief 16 
exposure to isoflurane provoked a strong arousal response, pupil dilation and calcium elevations in 17 
neurons and astrocytes. Arousal-induced cortical activity triggered an extracellular lactate surge that 18 
correlated with a fast and prominent lactate dip in astrocytes. After these initial events we observed a 19 
delayed rise in both astrocytic and neuronal lactate. The immediate drop in astrocytic lactate 20 
concentration and the subsequent lactate increase in the extracellular space suggests an activity-21 
dependent lactate release from astrocytes. Of interest, is that when β-adrenergic signaling was 22 
pharmacologically blocked the evoked lactate rise in both astrocytes and neurons was significantly 23 
reduced. We provide here in vivo evidence that arousal triggers lactate release from astrocytes and a 24 
rise in lactate levels, which is mediated by β-adrenergic signaling.  25 
3 
Introduction 26 
The brain is almost exclusively fueled by glucose oxidation 1,2. Acute elevations in brain activity are met 27 
with a transient net increase in aerobic glycolysis and the production of lactate 3,4 that is released into 28 
the extracellular space 5,6. However, the primary cellular source of this activity-driven lactate release 29 
remains a matter of debate 7-11. A long-standing hypothesis is that astrocytes increase their glycolysis 30 
in response to neuronal activity to cover neuronal ATP demand with lactate 8,12. Many studies have 31 
expanded this metabolic support model 3,13-15. Nevertheless, direct in vivo evidence of activity-evoked 32 
lactate release from astrocytes to neurons is still unavailable. Clearly, neurons are able to maintain 33 
their activity in vivo with a lactate supply 16 and an in vivo lactate gradient from astrocytes to neurons 34 
favors astrocytic shuttling of lactate to neurons 17. However, recent studies suggest that neurons 35 
increase their glycolytic activity upon stimulation and may also release lactate 18.  36 
 37 
At a behavioral level, lactate mobilization from glycogen, primarily stored in astrocytes, has been 38 
shown to promote long-term memory formation 6,19-22. In particular, emotionally-driven memory 39 
formation induced by stress or arousal, involves β-adrenergic signaling and lactate release from 40 
astrocytes 23. During arousal, noradrenaline released from locus coeruleus projections strongly 41 
activates astrocytes 24,25 and could have diverse metabolic functions, including glycogenolysis 26-28. 42 
Apart from serving as an energy substrate, lactate also regulates neuronal excitability by modulating 43 
ATP-sensitive potassium (KATP) channels 
29,30 or by direct action on membrane receptors 31,32. Thus, 44 
lactate signaling likely has diverse functions including the regulation of wakefulness, brain plasticity 45 
and memory consolidation 8,33.  46 
 47 
In this paper, we have addressed the way in which fast changes in cortical activity modulate lactate 48 
dynamics in astrocytes and neurons in awake behaving mice. We found that arousal triggers a rapid 49 
lactate release from astrocytes, which is followed by increased lactate levels in neurons. Theses 50 
arousal-evoked lactate surges were in part mediated by β-adrenergic signaling.  51 
4 
Results 52 
Cortical lactate dynamics in neurons and astrocytes in response to acute isoflurane exposure 53 
We have studied how state-dependent changes in cortical activity impact neuronal and astrocytic 54 
lactate levels by using genetically-encoded sensors for lactate, Laconic 34 and calcium, RCaMP 1.07 35 55 
and GCaMP6s 36 combined with two-photon microscopy imaging in awake behaving mice. (Figures 1D, 56 
E). Mice were trained for head-restrained, awake two-photon imaging using a suppression-response 57 
task with a water reward (Figures 1A, B; see Methods for details). Only mice that reached a 75 % 58 
correct trial performance during training were included for awake imaging (Figure 1C). During imaging 59 
sessions mice were exposed to isoflurane for 20 minutes (1.5 %; Figure S1A) while monitoring lactate 60 
level changes in cortical neurons and astrocytes (Figures S1B, C). Volatile anesthetics like isoflurane 61 
are well-known to induce changes in cortical activity 37-39. Exposure to isoflurane caused a significant 62 
increase in intracellular lactate levels in both astrocytes and neurons, levels which remained elevated 63 
during the isoflurane period (relative lactate signal rose by 4.6 ± 1.6% in neurons and 5.5 ± 2.0 % in 64 
astrocytes). Critically, at the onset of isoflurane exposure (within 10-20 s) we observed a significant 65 
and transient drop in lactate levels in astrocytes (Figure S1C; relative lactate signal dropped by -1.8 ± 66 
1.1 %, p = 0.03, Tukey post-hoc test). In contrast, neurons showed no significant lactate decrease when 67 
compared to baseline (p = 0.38, Tukey post-hoc test; Figure S1B). After stopping isoflurane, lactate 68 
levels completely recovered to baseline levels within 20.2 ± 6.0 min and 17.7 ± 7.1 min, in neurons and 69 
astrocytes respectively. In a similar manner, animal responsiveness and task performance (water 70 
licking) recovered within 20.7 ± 9.1 min (data not shown). 71 
 72 
Isoflurane exposure causes an initial arousal response before induction of anesthesia 73 
The biphasic lactate response observed in astrocytes upon isoflurane exposure, consisting of an initial 74 
dip, followed by a rise in lactate concentration (Figure S1C), could be triggered by distinct phases of 75 
isoflurane-induced brain states 38. Isoflurane and other general anesthetics are known to cause an 76 
initial arousal before the anesthetized state 39,40. Hence, we have carefully investigated the way in 77 
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which our isoflurane protocol impacts overall brain activity (Figure S2) and cortical calcium dynamics 78 
in neurons and astrocytes (Figure S3). 79 
  80 
First, we studied brain activity patterns with electroencephalography (EEG) recordings (Figures S2A-81 
D). Indeed, acute exposure to isoflurane did cause changes in EEG patterns (Figures S2A, B). Within 82 
seconds of isoflurane exposure, we observed a significant increase in high-frequency spectrum 83 
typically associated with cortical desynchronization 41,42. Cortical desynchronization was followed by 84 
an increase in slow-wave oscillations until EEG patterns reached the burst suppression found during 85 
deep anesthesia 43,44. The initial EEG band shifts observed upon isoflurane exposure (Figures S2C, D) 86 
strongly correlated with changes observed during an arousal response 41,45. This was further 87 
corroborated with electromyography (EMG) recordings (Figure S2E) as well as measurements of pupil 88 
size (Figure S2F 39,45,46). Consistent with our EEG recordings, seconds after isoflurane exposure, EMG 89 
electrical activity was significantly increased by 67.6 ± 21.5% and pupil diameter was increased by 51.3 90 
± 31.7 % (Figures S2G, H). In the subsequent anesthetized state, muscle activity (EMG) and pupil size 91 
were strongly reduced by 40.1 ± 16.5 % and 47.0 ± 17.1 %, respectively (Figures S2G, H). Taken 92 
together, our EEG, EMG and pupil size measurements identify a rapid and transient arousal response 93 
before the onset of the anesthetized state (Figure S2I).  94 
 95 
Arousal has been shown to evoke cortical calcium bursts in astrocytes 24,25 and neurons 45. We decided 96 
therefore to examine whether isoflurane-induced arousal would similarly lead to a cortical calcium 97 
response (Figure S3). Using a combination of two genetically-encoded calcium sensors RCaMP1.07 35 98 
and GCaMP6s 36 expressed in neurons and astrocytes, we monitored cellular calcium dynamics 100-99 
200 µm below the cortical surface with two-photon imaging (Figures S3B, C). Immediately upon 100 
isoflurane exposure there was a significant calcium elevation in both neurons and astrocytes (in 101 
neurons, whole frame fluorescence intensity increased by 24.2 ± 7.3%; p = 0.015; Figure S3B and in 102 
astrocytes, it increased by 84.7 ± 73.6 %; p < 0.001; Figure S3C). In addition, automated analysis of 103 
calcium signals 47,48 revealed a two-fold increase in calcium events in both neurons and astrocytes 104 
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(Figures S3D, E). Noteworthy, was that during the subsequent anesthetized state, whole frame 105 
fluorescence intensities for RCaMP1.07 and GCaMP6s were greatly reduced in neurons and astrocytes 106 
(-21.0 ± 7.2% and -29.4 ± 4.7%, Figures S3B, C). This was also consistent with a substantial loss in 107 
spontaneous activity in neurons and astrocytes when compared to baseline activity in the awake state 108 
(Figures S3D, E) as shown previously 49. Both calcium fluorescence intensities and event frequencies 109 
returned to baseline values when isoflurane application was stopped (Figures S3B-E). We find that the 110 
overall calcium dynamics observed in astrocytes and neurons are in line with our EEG, EMG and 111 
pupillometry measurements. 112 
 113 
Arousal triggers lactate release from astrocytes 114 
Our EEG, EMG and pupil size measurements, as well as our cortical calcium recordings, provide 115 
convincing evidence that when administered, isoflurane causes an immediate, strong arousal 116 
response. Thus, we wondered whether brief isoflurane pulses would lead to arousal-evoked cortical 117 
lactate fluctuations. We therefore adapted our protocol and exposed awake mice to a brief 20 s 118 
isoflurane pulse (ISO pulse; Figure 2A). As expected, the ISO pulse triggered a large pupil dilation 119 
without causing subsequent pupil constriction, indicating that we were only seeing an arousal 120 
response (Figure 2B). This was further corroborated by measuring neuronal and astrocytic calcium 121 
dynamics (Figures 2C, D). The application of an ISO pulse elicited a significant calcium transient in both 122 
neurons and astrocytes. Neuronal calcium levels were increased by 18.1 ± 7.2 % (Figure 2C) and 123 
astrocytic calcium levels by 67.5 ± 34.0 % (Figure 2D). Relevant to note, is that we did not observe the 124 
pronounced decrease in calcium fluorescence levels that occurred upon prolonged isoflurane 125 
exposure. Thus, the ISO pulse would seem to be an effective paradigm for which to study arousal-126 
mediated cortical metabolite dynamics in awake mice. 127 
 128 
Next, we examined the way in which arousal impacts lactate levels in cortical neurons and astrocytes. 129 
In both neurons and astrocytes, lactate levels were significantly increased by 2.4 ± 1.3 % (Figure 2E) 130 
and 3.6 ± 1.4 % (Figure 2F) respectively. Striking to note was that only in astrocytes revealed a 131 
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prominent lactate dip by 2.1 ± 1.4 % before the subsequent lactate surge (Figure 2F). This is in line with 132 
our earlier observations. We then compared the time courses of the arousal-evoked calcium and 133 
lactate responses in neurons and astrocytes (Figures 2G, H). Arousal-induced calcium and lactate 134 
recordings were each performed in the same animal using a multi-viral injection approach (Figure 1D; 135 
see Methods for details). In neurons, the evoked lactate surge appeared after the calcium transients 136 
(Figure 2G). In contrast, astrocytic changes in calcium and lactate levels occurred almost 137 
simultaneously (Figure 2H). The minimum of the astrocytic lactate dip coincided with the peak of the 138 
astrocytic calcium response (lactate dip: 0.26 ± 0.14 min vs. calcium peak: 0.18 ± 0.08 min; p = 0.24, 139 
Figure 2H). To further compare response kinetics between neurons and astrocytes, we computed the 140 
response slopes (Figure 2I) of the lactate elevations. Notably, despite the initial lactate dip, astrocytes 141 
displayed a significantly faster lactate rise compared to neurons (lactate slope astrocytes: 8.3 ± 1.1 142 
%/min and lactate slope neurons: 4.7 ± 3.3 %/min; p < 0.001, Figures 2G-I).  143 
 144 
The immediate arousal-mediated decrease in astrocytic lactate suggests an activity-dependent lactate 145 
consumption or release. If it were the latter, we might expect to detect an arousal-evoked lactate 146 
release from astrocytes with a concomitant increase in extracellular lactate levels. We therefore 147 
measured changes in extracellular space (ECS) lactate levels using a pre-calibrated lactate biosensor 148 
inserted into the somatosensory cortex (Figure 3A; see Methods for details). A brief isoflurane pulse 149 
caused extracellular lactate to rise significantly by 1.10 ± 0.15 mM (Figures 3B, C). Two distinct slopes 150 
were seen in these elevated ECS lactate levels. There was an initial, rapid lactate rise (S1: 25.8 ± 6.3 151 
µM/s) that peaked around 35 s post stimulus, which was followed by a second, significantly slower 152 
component (S2: 8.1 ± 3.8 µM/s; Figures 3B, C). We went on to compare the kinetics of the ECS, 153 
astrocytes, and neurons (Figures 3D-F). Two distinct phases in lactate dynamics were identifiable 154 
during the first 60 seconds: (I) A fast initial ECS lactate rise that coincided with the lactate decrease in 155 
astrocytes and (II) a slow delayed ECS lactate rise that coincided with the neuronal lactate increase 156 
(Figure 3F). The significant differences in lactate dynamics between the three compartments were 157 
further corroborated by direct comparison of the time series of lactate level changes and kinetics 158 
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within the initial 60 s of the arousal response (Figures 3G-I). Our data implies that arousal leads to 159 
rapid lactate release from astrocytes. 160 
 161 
β-adrenergic signaling mediates arousal-induced lactate level surges 162 
Noradrenaline, released form locus coeruleus projections during arousal events, has a strong impact 163 
on cortical activity 46,50 and is involved in modulating numerous cellular processes 24,25,51. In astrocytes, 164 
β-adrenergic signaling has been reported to shape emotionally-driven memory formation 23 and it is 165 
suggested that lactate shuttling from astrocytes to neurons plays a key role 6,19,22. Our experiments 166 
show that arousal impacts cortical lactate dynamics and that astrocytes are likely to release lactate 167 
upon cortical activation (Figures 2, 3). Our next test was to see whether β-adrenergic signaling 168 
mediates arousal-induced lactate dynamics. 169 
 170 
We used propranolol (10 mg/kg, i.p.), a non-selective β-adrenergic receptor blocker 27,52, to study how 171 
β-adrenergic signaling affects arousal-evoked calcium and lactate responses in astrocytes and neurons 172 
(Figures 4 and S5). Calcium and lactate recordings were performed before (0 h) and at several 173 
timepoints (1, 3, 6 and 24 h) after administering propranolol (Figure 4A). With accurate, repetitive 174 
imaging, we followed arousal-evoked responses in the same cells over time (Figure S4). Blocking β-175 
adrenergic receptors with propranolol did not impair evoked calcium transients in either neurons or 176 
astrocytes (Figure S5), a finding in line with previous reports 24,25. In contrast, propranolol had a 177 
significant impact on the induced lactate surges in both astrocytes and neurons (Figures 4B, C, E, F), 178 
but caused no overt changes in the astrocytic lactate dip (Figure 4D). Lactate surges (Figure 4E) and 179 
response slopes (Figure 4F) started to decrease compared to baseline responses within the first hour 180 
after drug injection. Six hours after propranolol injection, arousal-evoked lactate surges, measured as 181 
the area under curve (AUC), were reduced by 49.4 ± 40.2 % and 31.2 ± 32.5 % (p < 0.001 and p < 0.001). 182 
We also saw that the response slopes decreased by 35.3 ± 28.6 % and 34.7 ± 25.3 % (p < 0.001 and p = 183 
0.004) compared to baseline responses in neurons and astrocytes, respectively. Twenty-four hours 184 
after injection of propranolol, lactate responses recovered completely. Control experiments with 185 
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saline injections did not show any changes in the arousal-evoked calcium and lactate responses (Figure 186 
S6). In summary, β-adrenergic signaling appears to primarily regulate lactate production and 187 
mobilization rather than acting directly on the astrocytic lactate release machinery (Figure 5). 188 
10 
Discussion 189 
Acute brain activation is accompanied by an increase in aerobic glycolysis and surges in extracellular 190 
lactate 5,6. Our work here shows that arousal in mice elicits transient lactate elevations in cortical 191 
astrocytes, neurons and the extracellular space (Figure 3). Analysis of the temporal lactate dynamics 192 
in the three brain compartments revealed that astrocytes rapidly release lactate upon activation, with 193 
a corresponding rise in extracellular lactate. Neuronal lactate levels increased after the initial astrocytic 194 
lactate release concomitant with a slowing of the extracellular lactate surge. Our results thus provide 195 
evidence for arousal-induced astrocyte-to-neuron lactate shuttling in awake mice.  196 
 197 
New arousal paradigm during awake imaging in mice 198 
We have introduced here a new paradigm to elicit a robust and reproducible non-motor evoked 199 
arousal response in awake mice, with two-photon microscopy used for high spatiotemporal imaging. 200 
Acute exposure to isoflurane induces a rapid arousal response 38,39, which we identified carefully by 201 
measuring EEG, EMG, pupil size and cortical calcium responses. Pupil dilation occurred within seconds 202 
of an isoflurane stimulus. Tracking pupil diameter changes is a consistent method for monitoring 203 
wakefulness, switching between cortical states and arousal 39,45,46. Our EEG recordings during the initial 204 
seconds of isoflurane exposure are also in line with EEG profiles obtained from cortical responses to 205 
locus coeruleus stimulation 50,53. The activity of locus coeruleus projections is critical in the regulation 206 
of wakefulness and in promoting arousal 54,55. Arousal induced by forced locomotion or by air puffs has 207 
been shown to evoke calcium transients in cortical astrocytes 24,25,56 and in neurons 45. In a similar 208 
manner, our isoflurane-induced arousal protocol triggered a robust calcium response in both 209 
astrocytes and neurons. Important to note, is that by limiting isoflurane exposure to a brief 20 s pulse, 210 
we only produce arousal, while avoiding the subsequent sedative state that appears after prolonged 211 
isoflurane administration (Figure 2). This is substantiated by EEG, EMG, pupillometry and cellular 212 
calcium measurements that clearly allow for differentiation between the arousal response and the 213 
anaesthetized state (Figure S2). Moreover, a short 20 s isoflurane pulse avoids possible isoflurane side 214 
effects, such as the partial mitochondrial depolarization reported in cardiomyocytes after 15-30 min 215 
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of isoflurane application 57,58. We successfully established the isoflurane pulse paradigm to reliably 216 
evoke arousal in the absence of locomotion 46. Isoflurane is also a very strong sensory stimulus 38,39 and 217 
can be easily combined with behavioral training (water licking performance) during awake two-photon 218 
imaging (Figures 1, 2).  219 
 220 
Arousal triggers lactate release from astrocytes 221 
We used genetically-encoded sensors for calcium 35,36 and lactate 34 expression in cortical astrocytes 222 
and neurons to examine intracellular calcium and lactate dynamics in response to isoflurane-induced 223 
arousal (Figure 2). Moreover, with a pre-calibrated Pinnacle lactate biosensor 17,59,60 inserted into the 224 
cortex, we also studied arousal-evoked lactate fluctuations in the ECS (Figure 3). While monitoring 225 
lactate dynamics with high temporal resolution, we detected a rapid and significant lactate level 226 
decrease in only astrocytes upon arousal. The astrocytic lactate dip occurred almost simultaneously 227 
with the arousal-evoked calcium transients (Figure 2). In principle, this dip in astrocytic lactate could 228 
either be due to an increase in lactate consumption (conversion to pyruvate) or to an increased release 229 
of lactate. If the latter, then we would expect a corresponding, rapid increase in ECS lactate levels. 230 
Indeed, arousal-evoked ECS lactate dynamics revealed two distinct lactate response slopes. Striking to 231 
see was an initial, fast increase in ECS lactate of about 26 µM/s that coincided with the astrocytic 232 
lactate dip, suggesting that the rapid extracellular lactate rise is promoted by lactate release from 233 
astrocytes (Figure 3). A very similar fast lactate release from astrocytes has been reported in response 234 
to acute extracellular [K+] elevations in vitro, to electrical stimulation in vivo and in hippocampal slices 235 
13,61. Hence, a rise in extracellular [K+] during neuronal activity could rapidly stimulate neighboring 236 
astrocytes to release lactate, either through a lactate channel 13, monocarboxylate transporters 62 or 237 
possibly via pannexins 63.  238 
 239 
Arousal strongly induced cortical circuit activation as revealed by EEG and neuronal calcium recordings 240 
(Figures S2 and S3), in line with other studies 24,25,38,45. Neuronal stimulation was recently suggested to 241 
trigger neuronal lactate release 18. However, arousal-induced neuronal activation did not have a 242 
12 
neuronal lactate dip that corresponded with an extracellular lactate rise. On the contrary, neurons 243 
mainly showed increased lactate levels after the initial astrocytic lactate release (Figures 2, 3). This 244 
finding was not unexpected as it has been previously shown that neurons have a fast activity-245 
dependent calcium response but a delayed glycolytic response 18. In fact, the neuronal lactate increase 246 
coincides with a significant slowing of the extracellular lactate rise (3-fold decrease), suggesting that 247 
the neuronal lactate rise is driven by lactate uptake (Figure 3). Although neuronal activity may also 248 
stimulate glycolysis in neurons 18, it seems unlikely that neurons contain sufficient lactate for it to be 249 
released instantaneously. Astrocytes, on the other hand, have a higher basal glycolytic activity 64 as 250 
well as higher intracellular lactate levels in vivo 17. Thus, lactate release from this “pressure reservoir” 251 
in astrocytes could be rapidly triggered for export in an activity-dependent manner 65.  252 
 253 
The arousal-evoked lactate dip in astrocytes is directly followed by a lactate overshoot. This is best 254 
explained by having lactate production (aerobic glycolysis) surpassing lactate release. The extracellular 255 
lactate elevation period parallels the astrocytic and neuronal lactate surges, suggesting that an 256 
increased lactate production is strongly linked to lactate release and uptake respectively (Figure 5). 257 
Many activity-dependent neuronal signals have been shown to trigger lactate production by 258 
glycogenolysis and glycolysis in astrocytes. Astrocytic glycolysis has been seen to be promoted by 259 
glutamate, ammonium, nitric oxide and K+ 12-14,66 and glycogen breakdown is stimulated by vasoactive 260 
intestinal peptide, adenosine, noradrenaline and K+ 28,67. However, in response to arousal, the primary 261 
signal responsible for the astrocytic lactate production may well be noradrenaline as we discuss below.   262 
 263 
β-adrenergic signaling and arousal-induced lactate mobilization from astrocytes 264 
During arousal, noradrenaline is released throughout the brain from locus coeruleus projections 68. 265 
Noradrenergic signaling has been implicated in cognition and memory formation 69-71, particularly 266 
involving β-adrenergic receptors 72-74. A recent study highlighted that β2-adrenergic signaling in 267 
astrocytes is critical for emotionally-driven memory consolidation in mice 23. Blocking β-adrenergic 268 
signaling either pharmacologically with propranolol or by shRNA-mediated knockdown in astrocytes 269 
13 
but not in neurons, impaired long-term memory formation, which could be rescued by administering 270 
extracellular lactate 23. This impairment was attributed to noradrenaline-mediated glycogen 271 
breakdown and lactate release 28, which was reported to be important for long-term memory 272 
formation 6,19. Astrocytic β-adrenergic signaling may also impact glucose metabolism 27,75,76. 273 
 274 
We hypothesized that if β-adrenergic signaling is required to mobilize lactate in astrocytes, then we 275 
should see a perturbation of arousal-evoked cortical lactate dynamics with pharmacological inhibition. 276 
Indeed, 1 to 6 hours after a single intraperitoneal injection of propranolol (10 mg/kg), lactate surges in 277 
both astrocytes and neurons were strongly reduced (Figure 4). Notably, the astrocytic lactate dip was 278 
not overtly perturbed indicating that β-adrenergic signaling may not be necessary to facilitate lactate 279 
channel opening and/or transporter activity. In fact, astrocytes and neurons remained responsive to 280 
arousal-induced cortical activation, as calcium transients were not diminished by blocking β-adrenergic 281 
receptors (Figure S5). This is in line with arousal-mediated astrocytic calcium transients being primarily 282 
mediated by α-adrenergic but not β-adrenergic receptors 24,25. Hence, other activity-dependent 283 
mechanisms could stimulate the lactate release machinery in astrocytes, very likely mediated by an 284 
acute extracellular [K+] rise 13,61. High [K+] may also participate in the delayed increase in astrocytic 285 
lactate, through NBCe1-mediated stimulation of glycolysis 61,77,78 and glycogen degradation 67, acting 286 
in concert with the slower stimulation of astrocytic glycolysis by glutamate 12,77. 287 
 288 
Important to note is that while both astrocytes and neurons remained similarly responsive to arousal, 289 
indicating that workload and energy demand were unchanged during propranolol treatment, the 290 
subsequent reductions in arousal-evoked lactate surges in neurons and astrocytes are primarily caused 291 
by a partial deficit in lactate production. In astrocytes, but not in neurons, β-adrenergic signaling has 292 
been shown to impact emotionally-driven memory consolidation through a lactate-mediated 293 
mechanism 23. Thus, we assume that reductions in arousal-evoked lactate elevations in neurons are 294 
directly linked to a reduced lactate mobilization presumably from glycogen stores in astrocytes 295 
(Figures 4, 5). Although direct effects of β-adrenergic signaling on lactate production in cortical 296 
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neurons cannot be ruled out, it is more likely that astrocytes are critically involved in arousal-evoked 297 
lactate mobilization, since glycogen is predominantly stored in astrocytes 79,80, and lactate derived from 298 
glycogenolysis promotes memory formation 19 with a common lactate-dependent mechanism that is 299 
mediated by β-adrenergic signaling in astrocytes 23.  300 
 301 
Inhibition of β-adrenergic signaling via a single intraperitoneal propranolol injection (10 mg/kg) 302 
reduced arousal-evoked lactate surges in astrocytes by about 35 % around 6 h post injection (Figure 4). 303 
It could well be that β-adrenergic receptors were not fully inhibited by a single intraperitoneal injection 304 
and that a higher or prolonged dose, or a locally administered dose may even have an even stronger 305 
impact on glycogen or glucose metabolism, as previously suggested 23,81. As discussed above, other 306 
activity-dependent mechanisms are also likely to be involved in promoting lactate production, such as 307 
K+-mediated acceleration of glycolysis and glycogenolysis 67,77. Nonetheless, it is most interesting that 308 
a minimal perturbation of β-adrenergic signaling has such a strong impact on cortical lactate dynamics.  309 
 310 
In summary, our data favors an activity-induced astrocyte-to-neuron lactate shuttle. We provide in 311 
vivo evidence to show that arousal triggers lactate release from astrocytes and that astrocytic lactate 312 
mobilization is partly mediated by β-adrenergic signaling (Figure 5). This opens an exciting avenue for 313 
future studies to dissect activity-dependent mechanisms involved in lactate release and the dynamic 314 
interplay between astrocytes and neurons in the awake animal. Recent studies increasingly highlight 315 
that lactate is more than just an energy substrate and is critically involved in diverse signaling 316 
mechanisms 8,29-33. Hence, arousal-mediated lactate release from astrocytes could be crucial in fine-317 
tuning neuronal network activity and brain plasticity, which may also have clinical implications for 318 
various psychiatric disorders. 319 




All experimental and surgical procedures were approved by the local veterinary authorities according 323 
to the guidelines of the Swiss Animal Protection Law, Veterinary Office, Canton Zurich (Act of Animal 324 
Protection, 16 December 2005 and Animal Protection Ordinance, 23 April 2008). Female C57BL/6J 325 
(Charles River) mice weighing between 20 and 30 g were used in this study. All mice were kept in 326 
standardized single cages with food and water ad libitum. During experimental periods mice were 327 
subjected to water deprivation. Body weight was monitored before and after all training and 328 
experimental sessions. If body weight loss exceeded 15 % with respect to the baseline weight animals 329 
would be given free access to water until their weight had normalized. All housed animals were 330 
subjected to a 12/12 h light/dark cycle with the dark phase adjusted so that the animals were in their 331 
active phase during experimental periods. Surgical interventions were performed at age 10-15 weeks. 332 
 333 
Surgical interventions 334 
Surgical interventions were performed on two separate days. On the first day, the animals were 335 
anesthetized with isoflurane 1.5-2.0 % in a mixture of O2 and air (30/70 %) at a flow rate of 400 ml/min. 336 
Vitamin A ointment was applied to avoid corneal desiccation. To prevent dehydration 0.2 ml of saline 337 
solution was subcutaneously injected every hour. Animals were fixed in a stereotaxic frame (Model 338 
900; David Kopf Instruments) for the head-post implantation as previously described by Mayrhofer, et 339 
al. 82. In short, fur from the head and neck area was removed and after disinfection (Kodan; Schülke & 340 
Mayr) a 2 cm long midline incision was made between the eyes to the neck. A bonding agent (Gluma 341 
Comfort; Heraeus Kulzer) was applied after cleaning the skull and carefully separating the temporal 342 
muscle. Next, a head-cap was formed, made of multiple layers of light-curing dental cement (Synergy 343 
D6 Flow, Coltene AG). Finally, a custom-made aluminum head-post was attached, and open skin was 344 
attached to the implant with acrylic glue (Histoacryl; Braun).  345 
On the second day, a craniotomy was performed using a dental drill (OSSEODOC; Bien-Air), above the 346 
left somatosensory cortex, for intracortical virus injection. Animals were anesthetized with a mixture 347 
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of fentanyl (0.05 mg/kg bodyweight; Sintenyl, Sintetica), midazolam (5 mg/kg bodyweight; Dormicum, 348 
Roche), and medetomidine (0.5 mg/kg bodyweight; Domitor, Orion Pharma) injected intraperitoneally, 349 
and anesthesia was maintained with midazolam after 50 min (5 mg/kg bodyweight, subcutaneous). A 350 
facemask delivering oxygen was installed to prevent hypoxemia.  351 
For multi-viral injections in the somatosensory cortex, neighboring adeno-associated viral (AAV) 352 
injections (50-75 nl each) were delivered with a custom-made micro injector as described elsewhere 353 
17 to achieve multiple non-overlapping loci in the somatosensory cortex. The neuronal construct 354 
included a human synapsin-1 (hSYN) promoter and the astrocyte-specific construct included a minimal 355 
GFAP promoter (gfaABC1D). Transfection was performed by injecting: (A) a lactate sensor Laconic for 356 
neuronal (San Martin, et al. 34; AAV6-hSYN-Laconic; titer 1.02 E13 VG/ml); (B) for astrocytic (AAV9-357 
GFAP-Laconic; titer 3.1 E12 VG/ml); (C) calcium sensors RCaMP 1.07 for neuronal 35; AAV6-hSYN-358 
RCaMP 1.07; titer 2.4 E13 VG/ml) and (D) GCaMP6s for astrocytic (Chen, et al. 36; AAV9-GFAP-359 
GCaMP6s; titer 3.2 E13 VG/ml) expression, diluted 5-30 times in physiological saline. Injections were 360 
performed via a glass capillary to a cortical depth of 300 µm through the intact dura. Large blood 361 
vessels were avoided to prevent bleeding and the absorption of light by hemoglobin during imaging. 362 
For later chronic optical measurements, a square sapphire glass (3×3 mm, Powatec GmbH) was gently 363 
placed on the dura mater and sealed with light-curing dental cement (Synergy D6 Flow, Coltene AG). 364 
 365 
Behavioral training 366 
A custom-made head fixation box was built for chronic imaging and constant positioning of the animal. 367 
The response-suppression task used in this study was designed to suppress movement for 8 s periods 368 
while images from the cortex were acquired. After 8 s a tone was sounded to indicate the end of each 369 
period (reward stimulus). As a reward stimulus a 70 dB click noise of 1 ms duration with 2-18 kHz 370 
bandwidth was produced (background noise was 50 dB) and delivered by stereo speakers positioned 371 
20 cm away from the animals’ head. A drinking spout that included a piezo sensor (LDT0-028K; 372 
Measurement Specialties) was mounted in front of the animal. The spout was connected to a solenoid 373 
valve (Type 0330; Burkert) that controlled water delivery upon spout deflection. A custom-made piezo 374 
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movement sensor for monitoring movement was positioned under the animals’ body. A camera 375 
(191133; Conrad Electronic AG) with an infrared light source (BL0106-15-28; Kingbright Electronics) 376 
was used for monitoring animals. We used the custom-written LabVIEW program (National 377 
Instruments) and multifunctional data acquisition cards to control and monitor all components of the 378 
behavioral apparatus 83. We used a similar protocol to that developed by Mayrhofer, et al. 83 to adapt 379 
the animals to the experimental environment. Animals were first handled and familiarized with the 380 
experimenter, one week after implantation, for at least 3 times a day. They were adapted to water 381 
deprivation 12 h before training sessions and accustomed to tolerate head fixation and to drink water 382 
from a spout every 2 s during training sessions. Finally, the animals were trained in two daily sessions 383 
not to move for up to 8 s until the reward stimulus was presented. Occurrence of movement during 384 
this period led to a temporal delay of the reward stimulus. Delay was computed depending on the time 385 
point and the duration of movement within the normal movement-suppression window. After 386 
sounding of each tone, the animal was given a 1.5-second-long “window of opportunity” to lick on the 387 
spout. After the reward stimulus was triggered by a spout deflection (stimulus-response), there was a 388 
water release of 0.002 ml water per trial (referred to as “reward on lick”). All licks were registered. 389 
Licks within the suppression window were counted as false licks. Detected licks within the window of 390 
opportunity were counted as correct trials. We computed the number of correct trials for each training 391 
session to evaluate performance and training progress of all animals. 392 
 393 
Isoflurane experiments 394 
In the first set of experiments we collected 10 min baseline (50 trials) where the animal was performing 395 
the behavioral paradigm, followed by isoflurane administration for 20 min (1.5 % isoflurane in O2 and 396 
air (1:2) and 400 ml/min total flow rate) and a recovery phase after turning isoflurane off, for 30 min 397 
without anesthesia. In the second set of experiments a baseline of 5 min was acquired followed by 398 
administration of isoflurane for 20 s (1.5 %) and a recovery phase of 14 min and 40 s. This protocol was 399 
also used for 5 sequential imaging sessions at 1, 3, 6 and 24 h after the initial recording at 0 h. 400 
 401 
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EEG, EMG, pupil size and ECS recordings 402 
Electroencephalogram (EEG), electromyogram (EMG) and extracellular glucose and lactate 403 
measurements were performed with a commercially-available recording system (4-channel 404 
EEG/EMG/BIO Tethered System; Pinnacle Technology). All mice had a head-post mounted as 405 
previously described and regions of interest were spared from dental cement. Two to five days after 406 
the head-post was mounted, the skull was opened with a dental drill. Two EEG screws were implanted 407 
bilaterally in the frontal area, 2 screws (#8403; Pinnacle Technology) in the occipital area, a guide 408 
cannula (#7032; Pinnacle Technology) was implanted into the primary somatosensory cortex, wired 409 
with a head mount (#8402; Pinnacle Technology) and fixed with dental cement. Two EMG electrodes 410 
were placed in the neck muscle of the animal. After a recovery period of 2 weeks, the pre-calibrated 411 
lactate biosensor (#7004; Pinnacle Technology) was inserted into the guide cannula. Prior to 412 
implantation each lactate biosensor was calibrated in vitro to ensure selectivity and sensitivity for 413 
lactate. Data was acquired at 250 Hz for EEG and 1 Hz for lactate measurements. For pupil size 414 
measurements the camera (see above) for monitoring the animal was used, having the pupil 415 
approximated as a circle-like structure with a custom-written MATLAB algorithm used to compute 416 
changes in pupil radius. 417 
 418 
Microscope design and imaging parameters 419 
A custom-made two-photon laser scanning microscope 84 equipped with a two-photon laser with <120 420 
fs temporal pulse width (InSight DeepSee Dual; Spectra-Physics) with a 20x water immersion objective 421 
(W Plan-Apochromat 20x/1.0 DIC VIS-IR; Zeiss) was used for image acquisition. Excitation and emission 422 
beam paths were separated by a dichroic mirror (F73-825; AHF Analysentechnik). A dichroic mirror at 423 
506nm (F38-506; AHF Analysentechnik) and 560nm (F38-560; AHF Analysentechnik) separated the 424 
emission light beam. The emission light was focused on the photomultiplier (H9305-03, Hamamatsu) 425 
by two lenses (LA1050-A1 and AL5040-A2; Thorlabs). We used emission filters for blue (F39-477; AHF 426 
Analysentechnik), green and yellow (F37-545; AHF Analysentechnik) and red (F39-608; AHF 427 
Analysentechnik) for multi-color imaging. Data was acquired from the somatosensory cortex 100-200 428 
19 
µm below the cortical surface. Anatomical imaging was performed at a resolution of 512×512 pixels at 429 
a frequency of 0.74 Hz. Emission signals were acquired at 11.84 Hz and with a 128×256-pixel resolution. 430 
ScanImage 85 and custom-written LabVIEW software (National Instruments) were used for image 431 
control and data acquisition. 432 
 433 
Drug application 434 
Propranolol, a β-adrenergic receptor antagonist, in saline, was injected intraperitoneally (i.p.) at a 435 
concentration of 10 mg/kg. For control experiments, only saline was injected. 436 
 437 
Data analysis and statistics 438 
Data processing and analysis was carried out with MATLAB 2017a (MathWorks, Natick, USA) and 439 
ImageJ 86. Calcium and ratiometric data was analyzed with the MATLAB toolbox Cellular and 440 
Hemodynamic Image Processing Suite 47. Regions of interest (ROIs) were manually selected in ImageJ 441 
using high resolution 512×512-pixel images. All calcium data was analyzed with the activity-based 442 
plugin FLIKA in CHIPS. For data cross-correlation corrplot from MATLAB’s econometrics toolbox was 443 
used, with a Pearson’s linear correlation coefficient at a significance level of 0.05. The MATLAB plotter 444 
function was used to compute data distribution histogram of correlated data. Statistical analyses were 445 
performed with t-test. Experimental means were used for time series comparison. For numerical 446 
integrations of the area under the curve (AUC), the MATLAB trapz function was used. Statistical 447 
analyses and calculations were performed in R using the lme4 package 87 for linear mixed-effects 448 
models and multivariate analysis. All data was reported and plotted as uncorrected means and 449 
standard deviation of the means (SD). P values for different parameter comparisons were obtained 450 
using the lsmeans or multcomp 88 packages with Tukey post-hoc tests. P values < 0.05 were considered 451 
significant and are indicated with an asterisk, P values < 0.01 with two and P values < 0.001 with three 452 
asterisks. 453 
  454 
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Figure legends 709 
Figure 1. Awake two-photon imaging to study cortical lactate and calcium dynamics in neurons and 710 
astrocytes. 711 
(A) Animals were trained for head-restrained, awake two-photon imaging. A water spout was used for 712 
reward delivery and a ventilation mask for isoflurane supply. (B) Workflow scheme of preparing mice 713 
for awake two-photon imaging. Following recovery from surgery and intracortical AAV injections, mice 714 
were trained for head-restrained imaging using a suppression-response task and a water reward. On 715 
average mice were ready for imaging at around 4 weeks after surgery. (C) Mean behavioral 716 
performance (gray) and learning progress (black) during training. On average mice performed 139 ± 33 717 
trials per session and 2835 ± 1320 total trials to reach the 75% performance criterion to be included 718 
for imaging. N = number of animals, n = number of sessions. (D) Cortical expression of genetically-719 
encoded lactate sensor Laconic 34, calcium sensor RCaMP 1.07 35 and GCaMP6s 36 imaged through a 720 
chronic cranial window. M = medial, L = lateral, C = cranial, R = rostral. (E) Representative images of 721 
Laconic expression in neurons (blue), Laconic in astrocytes (yellow), RCaMP 1.07 in neurons (red) and 722 
GCaMP6s in astrocytes (green) 100-200 µm below cortical surface. Fluorescence is given in pseudo-723 
colors. 724 
 725 
Figure 2. Arousal-induced calcium and lactate elevations in neurons and astrocytes. 726 
(A) Paradigm to induce arousal in awake mice, consisting of a 5 min baseline (awake), 20 s isoflurane 727 
exposure (ISO pulse) and a 14 min and 40 s post-stimulation period. (B) Brief ISO pulse induces pupil 728 
dilation (T5.2) without a subsequent miosis, as expected for an arousal response. White circles indicate 729 
pupil size approximation. (C, D) Neurons (C) and astrocytes (D) immediately respond with an increase 730 
in calcium (T5.2) upon ISO pulse. Relative calcium changes normalized to baseline are quantified at 731 
timepoints T2, T5.2, T7 and T20 (bar graphs). The timepoint of isoflurane onset (T5) is indicated by ISO. 732 
(E, F) Depicted are lactate level changes in neurons (E) and astrocytes (F). Arousal induces lactate level 733 
elevations in both cell types (T7). Note that only astrocytes reveal a significant dip in lactate levels 734 
immediately after ISO pulse (T5.2). Quantification of relative lactate level changes at timepoints T2, 735 
31 
T5.2, T7 and T20 (bar graphs). Data set comprises 226 neurons and 236 astrocytes. (G, H) Overlay of 736 
calcium (black) and lactate responses (red) in neurons (G) and astrocytes (H). Note that in astrocytes 737 
the evoked calcium response strongly coincides with the immediate, initial drop in lactate levels. 738 
Dashed lines are indicated for slope analysis (I). (I) Response slopes of the evoked lactate rise. 739 
Astrocytes revealed a faster lactate level rise compared to neurons (8.3 ± 1.1 %/min vs. 4.7 ± 3.3 %/min; 740 
p < 0.001). N = number of animals, n = number of experiments. Data is represented as mean ± SD (* = 741 
p < 0.05; ** = p < 0.01; *** = p < 0.001; Tukey post-hoc test). 742 
 743 
Figure 3. Lactate response kinetics suggest an activity-dependent release of lactate from astrocytes 744 
upon arousal. 745 
(A) Scheme of extracellular space (ECS) lactate recordings using a pre-calibrated Pinnacle lactate 746 
biosensor inserted into the somatosensory cortex. (B) ECS lactate level changes in response to arousal 747 
(ISO pulse). Note that the ECS lactate surge has two distinct slopes (S1 and S2) indicated by dashed red 748 
lines. (C) Quantification of ECS lactate surge at timepoints T5.2 and T7 (318.2 ± 60.7 µM and 1099.3 ± 749 
145.9 µM) and of the slopes S1 and S2 (25.8 ± 6.3 µM/s and 8.1 ± 3.8 µM/s). (D) For direct comparison 750 
of the arousal-evoked lactate responses of the three compartments: ECS data using a Pinnacle 751 
biosensor (B), astrocytes and neurons using Laconic (reproduced from Figure 3E and F). Data was 752 
binned into 12 s fragments for data visibility. Green section of curves indicates the first 60 s upon 753 
arousal (ISO pulse). T5.2 represents the first datapoint 12 s after ISO pulse. (E) Normalized lactate 754 
responses from astrocytes, neurons and ECS. Green shaded area indicates first 60 s upon ISO pulse. 755 
Note that the astrocyte lactate level dip coincides with the lactate level rise in ECS, whereas neuronal 756 
lactate levels follow the rise in ECS. (F) Magnification of the time course depicted in (E) to better 757 
visualize lactate response kinetics. Green shaded area indicates first 60 s upon ISO pulse and gray 758 
shaded area indicates margins of 2 times standard deviations (SD) of the baseline of all 3 recordings. 759 
Two distinct phases are highlighted. First phase (I): Lactate level drop in astrocytes parallels rise in the 760 
ECS; Second phase (II): Neuronal lactate rise slows down ECS lactate surge. (G-I) Time series 761 
comparison of normalized data from E between neuronal, astrocytic and ECS responses. Overall strong 762 
32 
positive linear relationship (R) between neurons, astrocytes and ECS. Scatter plots reveal distinct 763 
temporal kinetics within first 60 s of arousal (green dots and line). Red line indicates identity line and 764 
a correlation of 1. (G) Direct comparison of ECS with astrocytes upon arousal (T5.2 onwards) shows a 765 
decrease in association, a significant left shift from the identity line (red), in favor of ECS lactate 766 
increases, as revealed by the distribution of datapoints in the histogram. (H) ECS vs. neuron 767 
comparison displays similar kinetics to the ECS vs. astrocyte comparison with significant outliers and a 768 
left shift from the identity line towards ECS coordinate during arousal. (I) Comparing neurons to 769 
astrocytes shows a decrease in value proximity during the first minute after stimulation onset and a 770 
significant right shift of the values from the identity line (red line = correlation of 1) as revealed by the 771 
distribution histogram due to the pronounced decrease in astrocytic lactate. Overall comparison 772 
reveals that ECS shows the fastest increase in lactate levels followed by astrocytes and neurons. ECS 773 
and neurons show no negative transients and only astrocytes show a dip. After arousal, response 774 
values return to the identity line and a linear relationship. Histogram showing data distribution 775 
compared to identity line and statistical analysis of differences between compartments (* = p < 0.05; 776 
** = p < 0.01; *** = p < 0.001, T-test). Arrow indicates first datapoint after ISO pulse (T5.2). Correlation 777 
(R) was computed with Pearson’s linear correlation coefficient at a significance level of 0.05. Data sets 778 
were normalized to 0 (baseline) and 1 (maximal response) for comparison. 779 
 780 
Figure 4. β-adrenergic signaling mediates arousal-evoked lactate surges. 781 
(A) Scheme to investigate propranolol (β-adrenergic antagonist) effects on arousal-induced lactate 782 
responses. Propranolol (10 mg/kg, i.p.) was injected after baseline acquisition (0 h). The same cells 783 
were imaged in subsequent sessions 1, 3, 6 and 24 h after the injection. (B, C) Evoked lactate response 784 
in neurons (B) and astrocytes (C) before (0 h) and after propranolol injection (1, 3, 6 and 24 h). The 785 
same 113 neurons and 118 astrocytes were monitored in 6 independent experiments per timepoint. 786 
(D) Quantification of the area under the curve (AUC) of the evoked lactate dip in astrocytes before (0 787 
h) and after propranolol (1 h - 24 h). The isoflurane-induced dip in astrocytes was not overtly affected 788 
by propranolol. (E) Arousal-induced lactate surges (AUC) in neurons (left) and astrocytes (right) before 789 
33 
(0 h) and after propranolol injection (1 h - 24 h). Blocking β-receptors resulted in a gradual decrease of 790 
the AUC in neurons and astrocytes. Maximal decreases were measured 6 h after propranolol injection 791 
(neurons: from 4.9 ± 3.3 %×min to 2.5 ± 2.0 %×min; p < 0.001; and astrocytes: from 7.3 ± 5.1 %×min to 792 
5.0 ± 3.4 %×min; p < 0.001). Responses recovered within 24 h after propranolol injection. (F) 793 
Quantification of response slopes in neurons (left) and astrocytes (right) before and after propranolol 794 
injection (0 h - 24 h). By 1 h after injection, slopes were already decreased. 6 h after injection neuronal 795 
response decreased from 5.5 ± 3.2 %/min to 3.6 ± 2.3 %/min (p < 0.001) and astrocyte response 796 
decreased from 7.9 ± 6.6 %/min to 5.1 ± 4.9 %/min (p = 0.004). Response slopes recovered within 24 797 
h. N = number of animals, n = experiments. Data is represented as mean ± SD (* = p < 0.05; ** = p < 798 
0.01; *** = p < 0.001, Tukey post-hoc test). 799 
 800 
Figure 5. Model of arousal-induced lactate mobilization from astrocytes. 801 
Arousal-induced cortical activity triggers an immediate lactate release from the astrocytic “pressure 802 
reservoir” 65. The gray shaded area represents steady-state lactate levels in all three compartments 803 
and highlights the lactate gradient from astrocytes to neurons 17. The activity-evoked drop in astrocytic 804 
lactate is paralleled by a rapid rise in extracellular lactate levels (I, red). This initial astrocytic lactate 805 
release is most likely driven by cellular depolarization and a rise in extracellular [K+] 13. Moreover, 806 
arousal induces release of noradrenaline (NA) that activates β-adrenergic receptors on astrocytes. β-807 
adrenergic signaling stimulates glycogenolysis in astrocytes, thereby promoting additional lactate 808 
production and release (II, blue). Neurons increase their lactate levels most likely by uptake of lactate, 809 
thereby slowing down the astrocyte-mediated extracellular lactate surge (II, blue). Neurons may 810 
already take up lactate in the initial phase (I, red) which may be directly used to fuel cellular activity 811 
(arousal-evoked calcium transients; Fig. 2) resulting in balanced uptake and consumption. Neuronal 812 
depolarization may also stimulate glycolysis in neurons, which may also contribute to the neuronal 813 
lactate rise 18. 814 
N = 11, n = 30
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Supplemental information 1 
Supplemental figures  2 
Figure S1. Lactate dynamics in cortical neurons and astrocytes upon acute isoflurane exposure. 3 
(Related to Figure 2) 4 
(A) Scheme of the prolonged isoflurane imaging paradigm consisting of a 10 min baseline (awake 5 
behaving), 20 min isoflurane and a 30 min recovery period. T indicates time in min throughout the 6 
imaging session. Timepoints for the onset (T10) and end (T30) of isoflurane delivery are indicated by 7 
START and STOP. (B, C) Cortical neurons (B, left panel) and astrocytes expressing Laconic (C, left panel) 8 
in individual fields of view. Single-cell fluorescence analysis of relative lactate changes (middle panels) 9 
during the isoflurane administration protocol (A). Both neurons and astrocytes show a rise in lactate 10 
levels that persists during the isoflurane period (indicated at T30) and returns to baseline during 11 
recovery (indicated at T60). Note, astrocytes revealed a significant lactate level drop shortly after 12 
isoflurane onset (C, indicated at T10.2). Bar graphs (right) summarize relative changes at T5, T10.2, T30 13 
and T60. N = number of animals, N = number of experiments. Data is represented as mean ± SD (* = p 14 
< 0.05; ** = p < 0.01; *** = p < 0.001, Tukey post-hoc test).  15 
Figure S2. Isoflurane exposure causes an initial arousal response before reaching the anesthetized 16 
state. (Related to Figure 2) 17 
(A) EEG raw traces at different timepoints of the isoflurane imaging paradigm (Figure S1A). Traces 18 
represent distinct states such as: T5 = awake behaving, T10.2 = induction and desynchronization, T30 19 
= anesthetized and increased slow-wave activity leading to burst suppression, T60 = recovery and 20 
awake. (B) EEG spectrum and EEG bands (delta: 0.5-4 Hz, theta: 4-8 Hz, alpha: 8-12 Hz, beta: 12-30 Hz 21 
and gamma: 30-50 Hz) show a clear shift in the power spectrum upon isoflurane exposure. Blue = low 22 
power (30 dB) and red = high power (90 dB). (C) EEG bands according to their power display a biphasic 23 
EEG response when transiting from the awake state through the induction phase (increase in high-24 
frequency power) to the anesthetized state (increase in low-frequency power). (D) Quantification of 25 
EEG bands as a relative change with respect to baseline at timepoints T5, T10.2, T30 and T60. During 26 
the initial induction phase (T10.2) high-frequency bands (gamma, beta) significantly increased whereas 27 
in the anesthetized state (T30) spectral power shifted to low-frequency bands. (E) EMG spectrum (10-28 
30 Hz) recorded from neck muscles shows an increase in muscle activity with exposure to isoflurane 29 
and a reduced power in the anesthetized state. Blue = low power (30 dB) and red = high power (90 30 
dB). (F) Pupillometry analysis reveals a pupil dilation in the induction phase (T10.2), then a pupil 31 
constriction in the anesthetized state (T30). White circles indicate approximate pupil sizes. (G) Relative 32 
changes in EMG power (black) and pupil radius (red) recorded during the isoflurane paradigm. (H) 33 
Quantification of EMG and pupil radius at timepoints T5, T10.2, T30 and T60. Note a significant increase 34 
in neuromuscular activity in the induction phase and a reduction in EMG power and pupil size during 35 
the anesthetized state. (I) Summary scheme highlighting that acute isoflurane exposure first initiates 36 
an aroused state (within the first 60 s), which is then gradually followed by an anesthetized state as 37 
determined by the EEG, EMG and pupil size analyses. N = number of animals, n = number of 38 
experiments. START and STOP indicate the period of isoflurane administration. Data is represented as 39 
mean ± SD (* = p < 0.05; ** = p < 0.01; *** = p < 0.001; Tukey post-hoc test).  40 
Figure S3. Calcium activity in neurons and astrocytes upon isoflurane administration. (Related to 41 
Figure 2) 42 
(A) Scheme of the prolonged isoflurane imaging paradigm consisting of a 10 min baseline (awake 43 
behaving), 20 min isoflurane and a 30 min recovery period. T indicates time in min for the course of 44 
the imaging session. Timepoints for the onset (T10) and end (T30) of isoflurane delivery are indicated 45 
by START and STOP. (B, C) Cortical neurons expressing calcium sensor RCaMP 1.07 (B, left panel) and 46 
astrocytes expressing GCaMP6s (C, left panel) in same field of view and spectrally separated. Whole 47 
frame fluorescence analysis of relative calcium changes (middle panels) during the isoflurane 48 
administration paradigm (A). The onset of isoflurane exposure (START) caused a strong activation in 49 
cortical network and a significant rise in neuronal and astrocytic calcium levels (T10.2). Overall calcium 50 
levels decreased in both cell types during the anesthetized state (T30) and recovered to baseline levels 51 
when mice returned to the awake state (T60). Bar graphs on the right summarize calcium level changes 52 
at timepoints T5, T10.2, T30 and T60. (D, E) Automated analysis to identify calcium events for neurons 53 
(D) and astrocytes (E) using MATLAB toolbox CHIPS (Barrett et al., 2018). Detected signals are indicated 54 
by colored ROI masks for timepoints T5, T10.2, T30 and T60 of the isoflurane administration paradigm 55 
(A). Quantification of the number of events detected during these timepoints are summarized in bar 56 
graphs (right). With isoflurane administration there is a significant increase in calcium events in both 57 
neurons and astrocytes (T10.2) compared to baseline (T5). Event frequencies are strongly reduced 58 
during the anesthetized state (T30) and recover back to baseline at T60. N = number of animals, N = 59 
number of experiments. ROI = region of interest. Data is represented as mean ± SD (* = p < 0.05; ** = 60 
p < 0.01; *** = p < 0.001, Tukey post-hoc test).  61 
Figure S4. Accurate recurring imaging allows repetitive monitoring of the same cortical neurons and 62 
astrocytes. (Related to Figure 4) 63 
(A-D) Repeated imaging of the same neurons and astrocytes over several timepoints (0, 1, 3, 6 and 24 64 
h; from left to right) for calcium (A, C) and lactate (B, D) measurements as used for the propranolol 65 
paradigm (Figure 4A). Similarity of field of views are given as correlation coefficients (R; top right) when 66 
compared to the first image of baseline acquisition (0 h). Correlation was computed with MATLAB 67 
toolbox CHIPS (Barrett et al., 2018). h indicates time in hours after starting the propranolol paradigm. 68 
Figure S5. Arousal-evoked calcium responses in neurons and astrocytes were unperturbed with 69 
propranolol. (Related to Figure 4) 70 
(A) Scheme of the paradigm used to investigate the effects of propranolol in neurons and astrocytes. 71 
Propranolol (10mg/kg, i.p.) was injected after baseline acquisition (0 h) and the same cells were imaged 72 
in subsequent sessions 1, 3, 6 and 24 h after injection. (B-E) Isoflurane pulse-evoked calcium changes 73 
in neurons (B, C) and astrocytes (D, E) at different timepoints before (0 h) and after propranolol 74 
injection (1, 3, 6 and 24 h). The evoked neuronal and astrocytic calcium responses (whole frame 75 
analysis) did not significantly change with propranolol treatment and signal amplitudes did not differ 76 
from control experiments with saline injections (Figure S4). N = number of animals, n = number 77 
experiments. ISO indicates the start of 20 s isoflurane application. Data is represented as mean ± SD. 78 
Figure S6. Control saline experiments of calcium and lactate responses in neurons and astrocytes. 79 
(Related to Figure 4) 80 
(A) Scheme of the control paradigm with saline for arousal-induced calcium and lactate responses in 81 
neurons and astrocytes (Figure 4A). The same cells as in the propranolol paradigm were monitored in 82 
sequential imaging sessions. (B, D) Evoked calcium responses in neurons (B) and astrocytes (D) before 83 
(0 h) and after saline injection (1 h - 24 h).  (C, E) Quantification of the amplitude of the evoked calcium 84 
responses in neurons (C) and astrocytes (E) before and after saline (0 h - 24 h). The isoflurane-induced 85 
calcium responses in neurons and astrocytes were not affected by saline injection. (F, H) Evoked lactate 86 
response in neurons (F) and astrocytes (H) before and after saline injection (0 h - 24 h). (G, I) 87 
Quantification of the AUC of the evoked lactate surge in neurons (G) and astrocytes (I) before and after 88 
saline injection (0 h - 24 h). The isoflurane-induced lactate response in neurons and astrocytes was not 89 
affected by saline injection. Data is represented as mean ± SD. AUC = area under the curve. N = number 90 
of animals, n = number of experiments. 91 
RecoveryAwake Isoflurane (1.5%)







N = 3, n = 6



















































T30 N = 3, n = 6
F
N = 3, n = 6
Change in pupil size
Relative change EMG and pupil
T5 T10.2 T30 T60
































































































































































T5 T10.2 T30 T60
100 μm






















N = 2, n = 6


























D Number of events in neurons
















































T30 N = 2, n = 6
RecoveryAwake Isoflurane (1.5%)







0 h 1 h 3 h 6 h 24 h
GCaMP6s in astrocytesC
100 μm
0 h 1 h 3 h 6 h 24 h
R = 1 R = 0.96 R = 0.97 R = 0.94 R = 0.92
R = 1 R = 0.96 R = 0.96 R = 0.95 R = 0.95
100 μm
Laconic in neuronsB
0 h 1 h 3 h 6 h 24 h
RCaMP 1.07 in neuronsA
100 μm
0 h 1 h 3 h 6 h 24 h
R = 1 R = 0.95 R = 0.94 R = 0.95 R = 0.97


























ISO ISO ISO ISO ISO























0 h 3 h 6 h 24 h1 h
ISO ISO ISO ISO ISO
N = 3, n = 6
A Paradigm with propranolol
Fig. 3A
0 h 1 h 3 h 6 h 24 h



























N = 3, n = 6




0h 3h 6h 24h1h










































ISO ISO ISO ISO ISO























0h 3h 6h 24h1h
ISO ISO ISO ISO ISO
N = 3, n = 6




0h 1h 3h 6h 24h
Figure S6
